2023 Q4 Form 10-Q Financial Statement
#000147793223008368 Filed on November 14, 2023
Income Statement
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
Revenue | $0.00 | $0.00 |
YoY Change | ||
Cost Of Revenue | ||
YoY Change | ||
Gross Profit | ||
YoY Change | ||
Gross Profit Margin | ||
Selling, General & Admin | ||
YoY Change | ||
% of Gross Profit | ||
Research & Development | ||
YoY Change | ||
% of Gross Profit | ||
Depreciation & Amortization | ||
YoY Change | ||
% of Gross Profit | ||
Operating Expenses | $182.3K | $290.0K |
YoY Change | -27.47% | 10.74% |
Operating Profit | -$287.5K | |
YoY Change | 9.79% | |
Interest Expense | $4.384M | $950.0K |
YoY Change | 138.62% | -2.39% |
% of Operating Profit | ||
Other Income/Expense, Net | -$3.898M | $1.116M |
YoY Change | -354.2% | 48.03% |
Pretax Income | $303.8K | $830.0K |
YoY Change | -90.26% | 68.6% |
Income Tax | ||
% Of Pretax Income | ||
Net Earnings | $303.8K | $828.8K |
YoY Change | -90.26% | 68.37% |
Net Earnings / Revenue | ||
Basic Earnings Per Share | ||
Diluted Earnings Per Share | $0.05 | $0.14 |
COMMON SHARES | ||
Basic Shares Outstanding | 591.9K shares | 7.129M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
SHORT-TERM ASSETS | ||
Cash & Short-Term Investments | $210.00 | $0.00 |
YoY Change | -99.95% | -100.0% |
Cash & Equivalents | $212.00 | $212.00 |
Short-Term Investments | ||
Other Short-Term Assets | $0.00 | $0.00 |
YoY Change | -100.0% | -100.0% |
Inventory | ||
Prepaid Expenses | $0.00 | $19.29K |
Receivables | ||
Other Receivables | ||
Total Short-Term Assets | $212.00 | $19.44K |
YoY Change | -99.97% | -97.63% |
LONG-TERM ASSETS | ||
Property, Plant & Equipment | ||
YoY Change | ||
Goodwill | ||
YoY Change | ||
Intangibles | ||
YoY Change | ||
Long-Term Investments | $6.589M | $6.500M |
YoY Change | -97.05% | -97.06% |
Other Assets | ||
YoY Change | ||
Total Long-Term Assets | $6.589M | $6.515M |
YoY Change | -97.05% | -97.06% |
TOTAL ASSETS | ||
Total Short-Term Assets | $212.00 | $19.44K |
Total Long-Term Assets | $6.589M | $6.515M |
Total Assets | $6.589M | $6.534M |
YoY Change | -97.05% | -97.06% |
SHORT-TERM LIABILITIES | ||
YoY Change | ||
Accounts Payable | ||
YoY Change | ||
Accrued Expenses | $241.1K | $206.1K |
YoY Change | 741.26% | 869.68% |
Deferred Revenue | ||
YoY Change | ||
Short-Term Debt | $216.5K | $200.0K |
YoY Change | ||
Long-Term Debt Due | ||
YoY Change | ||
Total Short-Term Liabilities | $593.3K | $430.2K |
YoY Change | 280.9% | 263.51% |
LONG-TERM LIABILITIES | ||
Long-Term Debt | $0.00 | $0.00 |
YoY Change | ||
Other Long-Term Liabilities | $552.0K | $1.000M |
YoY Change | -93.99% | -90.65% |
Total Long-Term Liabilities | $552.0K | $1.000M |
YoY Change | -93.99% | -90.65% |
TOTAL LIABILITIES | ||
Total Short-Term Liabilities | $593.3K | $430.2K |
Total Long-Term Liabilities | $552.0K | $1.000M |
Total Liabilities | $1.145M | $1.394M |
YoY Change | -87.73% | -87.11% |
SHAREHOLDERS EQUITY | ||
Retained Earnings | -$1.670M | -$1.900M |
YoY Change | -80.83% | -80.99% |
Common Stock | ||
YoY Change | ||
Preferred Stock | ||
YoY Change | ||
Treasury Stock (at cost) | ||
YoY Change | ||
Treasury Stock Shares | ||
Shareholders Equity | -$1.145M | -$1.375M |
YoY Change | ||
Total Liabilities & Shareholders Equity | $6.589M | $6.534M |
YoY Change | -97.05% | -97.06% |
Cashflow Statement
Concept | 2023 Q4 | 2023 Q3 |
---|---|---|
OPERATING ACTIVITIES | ||
Net Income | $303.8K | $828.8K |
YoY Change | -90.26% | 68.37% |
Depreciation, Depletion And Amortization | ||
YoY Change | ||
Cash From Operating Activities | -$1.060K | $0.00 |
YoY Change | -98.34% | -100.0% |
INVESTING ACTIVITIES | ||
Capital Expenditures | ||
YoY Change | ||
Acquisitions | ||
YoY Change | ||
Other Investing Activities | ||
YoY Change | ||
Cash From Investing Activities | ||
YoY Change | ||
FINANCING ACTIVITIES | ||
Cash Dividend Paid | ||
YoY Change | ||
Common Stock Issuance & Retirement, Net | ||
YoY Change | ||
Debt Paid & Issued, Net | ||
YoY Change | ||
Cash From Financing Activities | 0.000 | 0.000 |
YoY Change | ||
NET CHANGE | ||
Cash From Operating Activities | -1.060K | 0.000 |
Cash From Investing Activities | ||
Cash From Financing Activities | 0.000 | 0.000 |
Net Change In Cash | -1.060K | 0.000 |
YoY Change | -98.34% | -100.0% |
FREE CASH FLOW | ||
Cash From Operating Activities | -$1.060K | $0.00 |
Capital Expenditures | ||
Free Cash Flow | ||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q3 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001848861 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q3 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | ||
CY2023Q3 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2023Q3 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2023Q3 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7702242 | usd |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-09-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
001-41145 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
HEALTHCARE AI ACQUISITION CORP. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
E9 | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
98-1585450 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
8 The Green | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Ste 15614 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Dover | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
DE | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
19810 | ||
dei |
City Area Code
CityAreaCode
|
917 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
446-0469 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
true | ||
dei |
Entity Ex Transition Period
EntityExTransitionPeriod
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
true | ||
CY2023Q4 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
591851 | shares |
CY2023Q3 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
6514571 | usd |
CY2022Q4 | us-gaap |
Marketable Securities Noncurrent
MarketableSecuritiesNoncurrent
|
223048887 | usd |
CY2023Q3 | us-gaap |
Assets
Assets
|
6534011 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
223672996 | usd |
CY2023Q3 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
206095 | usd |
CY2022Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
28655 | usd |
CY2023Q3 | haia |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
216449 | usd |
CY2022Q4 | haia |
Promissory Note Related Party
PromissoryNoteRelatedParty
|
0 | usd |
CY2023Q3 | haia |
Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
|
7670 | usd |
CY2022Q4 | haia |
Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
|
127095 | usd |
CY2023Q3 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
430214 | usd |
CY2022Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
155750 | usd |
CY2023Q3 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
963871 | usd |
CY2022Q4 | us-gaap |
Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
|
1314370 | usd |
CY2023Q3 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
0 | usd |
CY2022Q4 | us-gaap |
Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
|
317285 | usd |
CY2023Q3 | haia |
Deferred Underwriting Commisions
DeferredUnderwritingCommisions
|
0 | usd |
CY2022Q4 | haia |
Deferred Underwriting Commisions
DeferredUnderwritingCommisions
|
7546840 | usd |
CY2023Q3 | us-gaap |
Liabilities
Liabilities
|
1394085 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
9334245 | usd |
CY2023Q3 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
6514571 | usd |
CY2022Q4 | us-gaap |
Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
|
223048887 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2022Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2022Q3 | us-gaap |
Profit Loss
ProfitLoss
|
492290 | usd |
CY2022Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | usd |
CY2023Q3 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
524380 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
0 | usd |
CY2023Q3 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-1899564 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8710675 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1374645 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8710136 | usd |
CY2023Q3 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
6534011 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
223672996 | usd |
us-gaap |
Operating Costs And Expenses
OperatingCostsAndExpenses
|
954754 | usd | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-954754 | usd | |
CY2023Q3 | haia |
Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
|
163452 | usd |
CY2022Q3 | haia |
Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
|
-219062 | usd |
haia |
Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
|
4660324 | usd | |
haia |
Interest Income Loss Securities Taxable
InterestIncomeLossSecuritiesTaxable
|
9200588 | usd | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-1275125 | usd | |
CY2023Q3 | haia |
Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
|
0 | usd |
CY2022Q3 | haia |
Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
|
0 | usd |
haia |
Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
|
0 | usd | |
haia |
Change In Fv Of Overallotment Option
ChangeInFvOfOverallotmentOption
|
155881 | usd | |
CY2023Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
1116370 | usd |
CY2022Q3 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
754163 | usd |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
5010823 | usd | |
us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
10631594 | usd | |
CY2023Q3 | us-gaap |
Profit Loss
ProfitLoss
|
828847 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
4024595 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
9676840 | usd | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8710136 | usd |
CY2023Q1 | haia |
Accretion Of Interest Earned On Trust Account To Common Stock Subject To Possible Redemption
AccretionOfInterestEarnedOnTrustAccountToCommonStockSubjectToPossibleRedemption
|
-2362839 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-225709 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-11298684 | usd |
CY2023Q2 | haia |
Accretion Of Interest Earned On Trust Account To Common Stock Subject To Possible Redemption
AccretionOfInterestEarnedOnTrustAccountToCommonStockSubjectToPossibleRedemption
|
-2134033 | usd |
CY2023Q2 | us-gaap |
Proceeds From Contributed Capital
ProceedsFromContributedCapital
|
524380 | usd |
CY2023Q2 | us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
7546840 | usd |
CY2023Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
3421457 | usd |
CY2023Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1940040 | usd |
CY2023Q3 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1374645 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-18393982 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-10691740 | usd |
CY2022Q2 | haia |
Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption
ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
|
-301900 | usd |
CY2022Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
1482308 | usd |
CY2022Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-9511332 | usd |
CY2022Q3 | haia |
Re Measurement Of Class A Ordinary Shares Subject To Possible Redemption
ReMeasurementOfClassAOrdinarySharesSubjectToPossibleRedemption
|
-973225 | usd |
CY2022Q3 | us-gaap |
Net Income Loss
NetIncomeLoss
|
492290 | usd |
us-gaap |
Profit Loss
ProfitLoss
|
4024595 | usd | |
us-gaap |
Profit Loss
ProfitLoss
|
9676840 | usd | |
haia |
Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
|
-4660324 | usd | |
haia |
Interest Earned On Marketable Securities Held In Trust Account
InterestEarnedOnMarketableSecuritiesHeldInTrustAccount
|
-1275125 | usd | |
haia |
Change In Warrant Liability
ChangeInWarrantLiability
|
-350499 | usd | |
haia |
Change In Warrant Liability
ChangeInWarrantLiability
|
-9200588 | usd | |
haia |
Change In Overallotment Liability
ChangeInOverallotmentLiability
|
0 | usd | |
haia |
Change In Overallotment Liability
ChangeInOverallotmentLiability
|
-155881 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-203606 | usd | |
us-gaap |
Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
|
-390540 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
177440 | usd | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-1355859 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
174119 | usd | |
us-gaap |
Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
|
90000 | usd | |
us-gaap |
Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
|
30000 | usd | |
us-gaap |
Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
|
42000 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-401063 | usd | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-1788073 | usd | |
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
0 | usd | |
us-gaap |
Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
|
-246766 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | usd | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-246766 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-401063 | usd | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-2034839 | usd | |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
401275 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
2500000 | usd |
CY2023Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
212 | usd |
CY2022Q3 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
|
465161 | usd |
us-gaap |
Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
|
0 | usd | |
us-gaap |
Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
|
36 | usd | |
haia |
Accretion Of Interest Earned On Shares To Cssr
AccretionOfInterestEarnedOnSharesToCssr
|
4760324 | usd | |
haia |
Accretion Of Interest Earned On Shares To Cssr
AccretionOfInterestEarnedOnSharesToCssr
|
1275125 | usd | |
us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
7546840 | usd | |
us-gaap |
Payments For Underwriting Expense
PaymentsForUnderwritingExpense
|
0 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
177095 | usd | |
us-gaap |
Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
|
0 | usd | |
haia |
Deferred Offering Costs Assumed By Related Party Charge To Additiona Paid In Capital
DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionaPaidInCapital
|
347285 | usd | |
haia |
Deferred Offering Costs Assumed By Related Party Charge To Additiona Paid In Capital
DeferredOfferingCostsAssumedByRelatedPartyChargeToAdditionaPaidInCapital
|
0 | usd | |
haia |
Redemption Of Shares From Marketable Securities Held In Trust Account
RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount
|
221294640 | usd | |
haia |
Redemption Of Shares From Marketable Securities Held In Trust Account
RedemptionOfSharesFromMarketableSecuritiesHeldInTrustAccount
|
0 | usd | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
100000 | usd | |
us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
0 | usd | |
CY2023Q2 | us-gaap |
Assets Held In Trust
AssetsHeldInTrust
|
50000 | usd |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement and the reported amounts of revenues and expenses during the reporting period.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</p> | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</p> | ||
us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued stock purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and ASC Topic 815, “Derivatives and Hedging—Contracts in Entity’s Own Equity” (“ASC 815”). The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is re-assessed at the end of each reporting period. In accordance with ASC Topic 825 “Financial Instruments,” offering costs attributable to the issuance of the derivative warrant liabilities have been allocated based on their relative fair value of total proceeds and are recognized in the statement of operations as incurred.</p> | ||
CY2022Q4 | us-gaap |
Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
|
223048887 | usd |
haia |
Founder Shares
FounderShares
|
1437500 | shares | |
haia |
Amount Of New Sponser Loaned
AmountOfNewSponserLoaned
|
116449 | usd | |
haia |
Amount Interest Bearing And Unsecured Promissory Note
AmountInterestBearingAndUnsecuredPromissoryNote
|
1500000 | usd | |
CY2022Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 |